☆ 4.8 Article

Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: Therapeutic avenues

Madeeha H. Sheikh et al.

Summary: Mounting evidence suggests a link between metabolic disease and neurovascular disorders and cognitive decline. This study used mouse models and post-mortem brains of T2DM patients to show that metabolic disease damages the blood-brain barrier (BBB), leading to increased leukocyte extravasation and neuroinflammation. Therapeutic interventions such as pharmacological treatment and dietary changes were found to reduce BBB damage.

FASEB JOURNAL (2022)

Add to Collection

Review Immunology

Pathological sequelae of long-haul COVID

Saurabh Mehandru et al.

Summary: This review examines the underlying pathophysiological mechanisms of post-COVID-19 syndromes, including persistent inflammation, induced autoimmunity, and putative viral reservoirs. The disease is called 'long-haul COVID' or 'post-COVID-19 syndrome', and clinical symptoms include fatigue, dyspnea, and neuropsychiatric syndromes.

NATURE IMMUNOLOGY (2022)

Add to Collection

Review Clinical Neurology

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

Ahmed Abdelhak et al.

Summary: Blood-derived biomarkers, such as glial fibrillary acidic protein (GFAP), hold promise in the diagnosis and prognosis of neurological diseases. However, there are limitations that hinder the widespread clinical use of GFAP as a biomarker.

NATURE REVIEWS NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis

Yuri Matteo Falzone et al.

Summary: NfL is a useful biomarker for the diagnosis of ALS and the strongest predictor of survival. UCHL1 is an independent prognostic factor helpful in stratifying survival in patients with low NfL levels, likely to have slowly progressive disease. GFAP reflects extramotor involvement, namely cognitive impairment or frontotemporal dementia.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19

Ettore Beghi et al.

Summary: Despite increasing reports on neurological manifestations of COVID-19, few studies have assessed the short- and long-term outcomes of the disease. This cohort study found that neuro-COVID is a severe disease associated with worse functional status at discharge, particularly in older subjects and those with comorbidities and acute complications of infection.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy

Pier M. Mannucci et al.

Summary: This study analyzed data from COVID-19 survivors in Lombardy to reveal the increased rates of rehospitalization, emergency room visits, and outpatient visits in the 6 months following recovery. Various medical tests and drug usage also significantly increased, indicating an increased burden on healthcare resources in the post-COVID-19 condition.

JOURNAL OF INTERNAL MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Persistent COVID-19 symptoms in a community study of 606,434 people in England

Matthew Whitaker et al.

Summary: This study characterizes Long COVID using data from the REACT-2 community-based study in England, estimating the prevalence of persistent symptoms and identifying risk factors. It also finds evidence of symptom clustering.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Clinical Neurology

GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask

Damir Janigro et al.

Summary: Traumatic brain injury is a major global health issue with significant consequences. Early diagnosis of TBI through testing peripheral fluids has been the focus of research, leading to the development of clinical tools. However, unresolved issues still exist and further research and improvements are needed.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study

Ingibjorg Magnusdottir et al.

Summary: This study investigated the long-term mental health of COVID-19 patients and found that severe illness is associated with long-term mental morbidity among recovering individuals. These findings highlight the importance of monitoring the mental health of patients with severe acute phases of COVID-19.

LANCET PUBLIC HEALTH (2022)

Add to Collection

Letter Medicine, General & Internal

Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers

Elena Azzolini et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Review Medicine, General & Internal

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review

Kin Israel Notarte et al.

Summary: This systematic review investigates the association between COVID-19 vaccination and long-COVID symptoms. The findings suggest that vaccination is associated with reduced risks of long-COVID, with preliminary evidence showing that two doses are more effective than one dose. The impact of vaccination on people with existing long-COVID symptoms is still controversial.

ECLINICALMEDICINE (2022)

Add to Collection

Article Clinical Neurology

Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses

Edward J. Needham et al.

Summary: COVID-19 and influenza are both associated with brain injury, particularly in severe cases. The brain injury occurs in the context of dysregulated immune responses, with no single pathogenic mechanism clearly responsible. Blood biomarkers can be used to assess the extent and duration of brain injury.

BRAIN (2022)

Add to Collection

Article Neurosciences

Microglia-derived CCL2 has a prime role in neocortex neuroinflammation

Mariella Errede et al.

Summary: In this study, the neocortex of EAE-affected mice was investigated to understand the mechanisms involved in the pathogenesis of EAE and the effects of MSC treatment. The results showed that hypertrophic microglia are the primary source of CCL2 in EAE-affected mice. Treatment with MSCs reduced microgliosis, CCL2 expression, and preserved/restored BBB features.

FLUIDS AND BARRIERS OF THE CNS (2022)

Add to Collection

Article Clinical Neurology

Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy

Nicola Rifino et al.

Summary: This study provides an extensive overview on the major neurological complications in a large cohort of COVID-19 patients. The results show that neurological manifestations of COVID-19 include cerebrovascular disease, peripheral nervous system diseases, altered mental status, and other disorders. The study confirms that involvement of the nervous system is common in SARS-CoV-2 infection.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

Microvascular Injury in the Brains of Patients with Covid-19

Daniel P. Perl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Interactions of SARS-CoV-2 with the Blood-Brain Barrier

Michelle A. Erickson et al.

Summary: This review discusses the mechanisms by which SARS-CoV-2 interactions with the blood-brain barrier (BBB) may lead to neurological dysfunction associated with COVID-19. It considers peripheral diseases such as hypoxia and systemic inflammatory response syndrome, as well as CNS infection and viral entry into the brain. Additionally, it explores the contribution of risk factors for severe COVID-19 to BBB dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Cell Biology

Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury

Neil S. N. Graham et al.

Summary: Plasma NfL serves as a sensitive and clinically meaningful measure of axonal injury resulting from TBI, validated through advanced MRI, cerebral microdialysis, and experimental models. The results support the incorporation of NfL sampling into clinical practice to aid in diagnosis and improve prognosis.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19

Anne Hege Aamodt et al.

Summary: Elevated concentrations of NfL and GFAp in COVID-19 patients upon admission may indicate increased mortality risk, and these biomarker concentrations are associated with clinical outcomes.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Neurological update: COVID-19

A. L. Ren et al.

Summary: COVID-19 is primarily a respiratory disease, but can also lead to neurological complications. The main processes causing neurological damage include cerebrovascular disease, immunologically mediated neurological disorders, and the harmful effects of critical illness on the nervous system. While it is still uncertain if the virus directly invades the nervous system, the large number of infections at present suggests that nervous system infection may not be a significant issue.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease

Erin F. Balcom et al.

Summary: COVID-19 is a global pandemic caused by SARS-CoV-2 infection, leading to acute and chronic disorders affecting the nervous system. Acute neurological symptoms include stroke, seizures, and cognitive dysfunction, while chronic neurological sequelae such as exercise intolerance and pain are reported. Various studies suggest potential mechanisms of viral neuroinvasion, but further research is needed to understand the underlying pathogenic processes.

BRAIN (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

The emerging role of perivascular cells (pericytes) in viral pathogenesis

Teemapron Butsabong et al.

Summary: Viruses can interact with pericytes to cause vascular leakage or haemorrhage, influencing microvascular function and viral pathogenesis. Pathogenic mechanisms may include direct infection or modulation by secreted viral gene products.

JOURNAL OF GENERAL VIROLOGY (2021)

Add to Collection

Article Microbiology

Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comte Hospital, France

Souheil Zayet et al.

Summary: More than a third of COVID-19 patients experienced persistent symptoms after SARS-CoV-2 infection, with a particular focus on loss of smell, loss of taste, fatigue, and dyspnea. Among COVID-19 outpatients, healthcare workers had a higher prevalence of post-COVID-19 syndrome.

MICROORGANISMS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma

Jiejie Geng et al.

Summary: SARS-CoV-2 mutations increase viral transmissibility and immune escape, requiring in-depth investigation on COVID-19 pathogenesis for strategy development. CD147 is identified as a universal receptor for SARS-CoV-2 and its variants, and Meplazeumab effectively inhibits viral entry and inflammation.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration

Ling Zhang et al.

Summary: The study found evidence supporting that SARS-CoV-2 can cross the blood-brain barrier in transcellular pathways based on experiments in mice and hamsters. The transmission pathway involves disrupted basement membrane without obvious alteration of tight junctions.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

Huijie Bian et al.

Summary: The study found that blocking CD147 with anti-CD147 antibody could suppress SARS-CoV-2 replication, and meplazumab may effectively prevent infection in COVID-19 patients. The safety and efficacy of meplazumab were demonstrated in healthy volunteers and COVID-19 patients, indicating its potential in treating COVID-19 pneumonia.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Article Microbiology

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)

Laurent Softic et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Add to Collection

Review Chemistry, Medicinal

Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview

Subha Mondal et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Surgery

Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

Beatriz Rodriguez-Cubillo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Add to Collection

Article Clinical Neurology

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

Nelly Kanberg et al.

NEUROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Ke Wang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Medicine, General & Internal

Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study

Qing Quan Liu et al.

BMJ OPEN (2020)

Add to Collection

Article Infectious Diseases

To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study

Else Quist-Paulsen et al.

BMC INFECTIOUS DISEASES (2019)

Add to Collection

Review Clinical Neurology

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection

Article Clinical Neurology

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Federico Verde et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection

Article Neurosciences

Pericytes as Inducers of Rapid, Matrix Metalloproteinase-9-Dependent Capillary Damage during Ischemia

Robert G. Underly et al.

JOURNAL OF NEUROSCIENCE (2017)

Add to Collection

Article Neurosciences

Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis

Laura Pasetto et al.

JOURNAL OF NEUROSCIENCE (2017)

Add to Collection

Review Pathology

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

Aylin Yilmaz et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)

Add to Collection

Article Medicine, General & Internal

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

Magnus Gisslen et al.

EBIOMEDICINE (2016)

Add to Collection

Review Neurosciences

Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia

Erica M. Weekman et al.

JOURNAL OF ALZHEIMERS DISEASE (2016)

Add to Collection

Review Neurosciences

The restorative role of annexin A1 at the blood-brain barrier

Simon McArthur et al.

FLUIDS AND BARRIERS OF THE CNS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

EMMPRIN, an upstream regulator of MMPs, in CNS biology

Deepak Kumar Kaushik et al.

MATRIX BIOLOGY (2015)

Add to Collection

Review Neurosciences

Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker

Zhihui Yang et al.

TRENDS IN NEUROSCIENCES (2015)

Add to Collection

Article Multidisciplinary Sciences

Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection

Julia Peterson et al.

PLOS ONE (2014)

Add to Collection

Review Clinical Neurology

Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies

Takashi Kanda

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Add to Collection

Article Clinical Neurology

An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Ralph L. Sacco et al.

STROKE (2013)

Add to Collection

Review Cell Biology

Cyclophilin A: a key player for human disease

P. Nigro et al.

CELL DEATH & DISEASE (2013)

Add to Collection

Article Multidisciplinary Sciences

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

Robert D. Bell et al.

NATURE (2012)

Add to Collection

Article Immunology

Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro

Fuyuko Takata et al.

JOURNAL OF NEUROINFLAMMATION (2011)

Add to Collection

Article Immunology

Guillain-Barre syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

James J. Sejvar et al.

VACCINE (2011)

Add to Collection

Article Microbiology

The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors

Susanne Pfefferle et al.

PLOS PATHOGENS (2011)

Add to Collection

Article Clinical Neurology

Blood-Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9

Taura L. Barr et al.

STROKE (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms

Kimio Satoh et al.

NATURE MEDICINE (2009)

Add to Collection

Article Endocrinology & Metabolism

Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat

Yi Yang et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)

Add to Collection

Article Biochemical Research Methods

Redox regulation of cyclophilin A by glutathionylation

P Ghezzi et al.

PROTEOMICS (2006)

Add to Collection

Article Immunology

Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages

H Kim et al.

CLINICAL IMMUNOLOGY (2005)

Add to Collection

Article Anatomy & Morphology

Astrocyte-endothelial interactions and blood-brain barrier permeability

NJ Abbott

JOURNAL OF ANATOMY (2002)

Add to Collection

Article Multidisciplinary Sciences

Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes

M Fratelli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.